Ontology highlight
ABSTRACT:
SUBMITTER: Deng M
PROVIDER: S-EPMC6296374 | biostudies-literature | 2018 Oct
REPOSITORIES: biostudies-literature
Deng Mi M Gui Xun X Kim Jaehyup J Xie Li L Chen Weina W Li Zunling Z He Licai L Chen Yuanzhi Y Chen Heyu H Luo Weiguang W Lu Zhigang Z Xie Jingjing J Churchill Hywyn H Xu Yixiang Y Zhou Zhan Z Wu Guojin G Yu Chenyi C John Samuel S Hirayasu Kouyuki K Nguyen Nam N Liu Xiaoye X Huang Fangfang F Li Leike L Deng Hui H Tang Haidong H Sadek Ali H AH Zhang Lingbo L Huang Tao T Zou Yizhou Y Chen Benjamin B Zhu Hong H Arase Hisashi H Xia Ningshao N Jiang Youxing Y Collins Robert R You M James MJ Homsi Jade J Unni Nisha N Lewis Cheryl C Chen Guo-Qiang GQ Fu Yang-Xin YX Liao X Charlene XC An Zhiqiang Z Zheng Junke J Zhang Ningyan N Zhang Cheng Cheng CC
Nature 20181017 7728
Immune checkpoint blockade therapy has been successful in treating some types of cancer but has not shown clinical benefits for treating leukaemia<sup>1</sup>. This result suggests that leukaemia uses unique mechanisms to evade this therapy. Certain immune inhibitory receptors that are expressed by normal immune cells are also present on leukaemia cells. Whether these receptors can initiate immune-related primary signalling in tumour cells remains unknown. Here we use mouse models and human cell ...[more]